Table 1 Patient characteristics
From: High sensitivity troponin-I threshold to predict perioperative myocardial infarction
No type-5 MI N = 352 | Type-5 MI N = 22 | All patients N = 374 | |
|---|---|---|---|
M ± SD | M ± SD | ||
Gender | |||
Female (N [%]) | 60 (17.0) | 4 (18.1) | 64 (17) |
Male | 292 (83.0) | 18 (81.9) | 310 (83) |
Age (mean ± SD) | 64.2 ± 10 | 65.81 ± 9.8 | 64.3 ± 10 |
Smoker | |||
Prior | 53 (15.1) | 7 (31.8) | 60 (16) |
Active | 116 (33.0) | 5 (22.7) | 121 (32) |
BMI | 29.2 ± 4.9 | 29.1 ± 2.8 | 29.2 ± 4.8 |
Creatinine* | 0.8 (0.72,1.1) | 0.84 (0.8,1.4) | 0.82 (0.79,1.2) |
LVEF | 52.2 ± 12.1 | 54.5 ± 12 | 52.3 ± 12.1 |
Hemoglobin | 13.3 ± 1.9 | 13.4 ± 2 | 13.3 ± 1.9 |
EuroSCORE II* | 2.4 (1.7, 4) | 3.3 (1.9, 5) | 2.4 (1.7, 4.1) |
Hypertension | 278 (79.0) | 19 (86.4) | 297 (79) |
Hyperlipidemia | 288 (81.8) | 19 (86.4) | 307 (82) |
CRF | 42 (12.0) | 2 (9.1) | 44 (11) |
DM2 | 187 (53.1) | 14 (63.6) | 201 (54) |
DM on insulin | 115 (32.7) | 11(50.0) | 126 (34) |
Chest pain | 18 (5.1) | 7 (31.8) | 25 (7) |
Acute coronary syndrome in the last 6 weeks | 128 (36.4) | 13 (68.4) | 141 (38) |
PVD | 181 (51.4) | 4 (19.0) | 185 (49) |
CVA/TIA | 37 (10.5) | 2 (9.1) | 39 (10) |
Atrial fibrillation | 19 (5.4) | 1 (4.5) | 20 (5) |
Acetylsalicylic acid | 238 (67.6) | 14 (63.6) | 352 (94) |
PY2I | 92 (26.1) | 6 (27.3) | 98 (26) |
Anticoagulation | 28 (8.0) | 1 (4.5) | 29 (8) |
Beta-blocker | 173 (49.1) | 10 (45.5) | 183 (49) |
Statin | 237 (67.3) | 14 (63.6) | 251 (67) |
ACE Inhibitors | 161 (45.7) | 6 (27.3) | 167 (45) |